No. I think economically they're completely different models.
In terms of the impact of cost recovery on the public purse, there's a fundamental difference between the two. As you pointed out, they're not covered by health plans. The reason they're not covered by health plans is that they're not considered eligible expenses under the medical expense tax credit. There are many ways in which taxpayer money is going into the prescription drug market. I'm not disputing the validity of that, but it does completely differentiate the two product categories.